rhodamine 123 has been researched along with abemaciclib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Z; Cheng, B; Fang, X; Fu, L; To, KKW; Wang, F; Wu, T | 1 |
1 other study(ies) available for rhodamine 123 and abemaciclib
Article | Year |
---|---|
Effect of abemaciclib (LY2835219) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
Topics: Aminopyridines; Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; Benzimidazoles; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Humans; Mice; Neoplasm Proteins; Rhodamine 123; Xenograft Model Antitumor Assays | 2017 |